Successful mycophenolate mofetil treatment of a patient with severe steroid‐refractory hepatitis evoked by nivolumab plus ipilimumab treatment for relapsed bladder cancer

Abstract

Abstract Mycophenolate mofetil resulted in rapid improvement of steroid‐refractory immune‐related adverse event hepatitis, induced by nivolumab plus ipilimumab.

Keywords

• hepatitis
• immune‐related adverse events
• ipilimumab
• mycophenolate mofetil
• nivolumab